Juvenile Neuropsychiatric Systemic Lupus Erythematosus: Identification of Novel Central Neuroinflammation Biomarkers - Archive ouverte HAL Access content directly
Journal Articles Journal of Clinical Immunology Year : 2022

Juvenile Neuropsychiatric Systemic Lupus Erythematosus: Identification of Novel Central Neuroinflammation Biomarkers

(1, 2, 3) , (4) , (5) , (1, 6) , (7, 8) , (1) , (1) , (1, 9, 10) , (11, 12) , (1) , (1, 2) , (1, 2, 13) , (1, 2) , (1, 2) , (1) , (14) , (1, 2, 6, 8) , (15) , (16) , (1) , (1, 2, 6, 17, 18) , (1, 2, 6) , (19) , (1, 2) , (19) , (1, 2) , (20) , (11, 21) , (21) , (22) , (21) , (11, 23) , (5) , (21, 24) , (1, 25) , (1, 2, 21, 26)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
Isabelle Hau
  • Function : Author

Abstract

Introduction Juvenile systemic lupus erythematosus (j-SLE) is a rare chronic autoimmune disease affecting multiple organs. Ranging from minor features, such as headache or mild cognitive impairment, to serious and life-threatening presentations, j-neuropsychiatric SLE (j-NPSLE) is a therapeutic challenge. Thus, the diagnosis of NPSLE remains difficult, especially in pediatrics, with no specific biomarker of the disease yet validated. Objectives To identify central nervous system (CNS) disease biomarkers of j-NPSLE. Methods A 5-year retrospective tertiary reference monocentric j-SLE study. A combination of standardized diagnostic criteria and multidisciplinary pediatric clinical expertise was combined to attribute NP involvement in the context of j-SLE. Neopterin and interferon-alpha (IFN-α) protein levels in cerebrospinal fluid (CSF) were assessed, together with routine biological and radiological investigations. Results Among 51 patients with j-SLE included, 39% presented with j-NPSLE. J-NPSLE was diagnosed at onset of j-SLE in 65% of patients. No specific routine biological or radiological marker of j-NPSLE was identified. However, CSF neopterin levels were significantly higher in active j-NPSLE with CNS involvement than in j-SLE alone ( p = 0.0008). Neopterin and IFN-α protein levels in CSF were significantly higher at diagnosis of j-NPSLE with CNS involvement than after resolution of NP features (respectively p = 0.0015 and p = 0.0010) upon immunosuppressive treatment in all patients tested ( n = 10). Both biomarkers correlated strongly with each other ( R s = 0.832, p < 0.0001, n = 23 paired samples). Conclusion CSF IFN-α and neopterin constitute promising biomarkers useful in the diagnosis and monitoring of activity in j-NPSLE.
Fichier principal
Vignette du fichier
s10875-022-01407-1.pdf (906.64 Ko) Télécharger le fichier
Origin : Publication funded by an institution
Licence : CC BY - Attribution

Dates and versions

pasteur-03889611 , version 1 (08-12-2022)

Licence

Attribution - CC BY 4.0

Identifiers

Cite

Mathilde Labouret, Stefania Costi, Vincent Bondet, Vincent Trebossen, Enora Le Roux, et al.. Juvenile Neuropsychiatric Systemic Lupus Erythematosus: Identification of Novel Central Neuroinflammation Biomarkers. Journal of Clinical Immunology, 2022, ⟨10.1007/s10875-022-01407-1⟩. ⟨pasteur-03889611⟩
0 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More